John F. Hannigan
John F. Hannigan publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology and Gastric Cancer Management and Outcomes.
- World rank
- #871,251 of 7,710,434 ranked researchers
- Rank in United States
- #288,226 of 1,627,098
- Works
- 32
- Citations
- 2.5k
- Citations per work
- 76.9
What does John F. Hannigan research?
John F. Hannigan's work is mostly in Medicine (48%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1548.4%
- Medicine1548.4%
- Everything else1444.9%
- Life Sciences26.7%
- 1Oncology19% of their works
- 2Pulmonary and Respiratory Medicine12% of their works
- 3Surgery8% of their works
- 4Molecular Biology7% of their works
- 5Pathology and Forensic Medicine4% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Gastric Cancer Management and Outcomes
- Statistical Methods in Clinical Trials
- Bladder and Urothelial Cancer Treatments
- Sexual Differentiation and Disorders
- Chemotherapy-induced cardiotoxicity and mitigation
- Dermatology and Skin Diseases
Which keywords describe John F. Hannigan's research?
The keywords of their largest research topics: Chemotherapy, Molecular Characterization, Cetuximab, KRAS Mutations, Chemotherapy-Induced Peripheral Neuropathy, Endoscopic Resection, Gastric Cancer and Taxanes.
- Steroid 21-Hydroxylase Deficiency
- Filaggrin
- Congenital Adrenal Hyperplasia
- Urothelial Carcinoma
- Bladder Cancer
- Taxanes
- Endoscopic Resection
- KRAS Mutations
- Molecular Characterization
- Chemotherapy
- Cetuximab
- Chemotherapy-Induced Peripheral Neuropathy
- Gastric Cancer
- Adaptive Designs
- False Discovery Rate
- Anthracyclines
- Doxorubicin
- Skin Microbiome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Chemotherapy154 topics
- Molecular Characterization72 topics
- Cetuximab61 topic
- KRAS Mutations61 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Endoscopic Resection41 topic
- Gastric Cancer41 topic
- Taxanes41 topic
- Adaptive Designs31 topic
- Bladder Cancer31 topic
- False Discovery Rate31 topic
- Urothelial Carcinoma31 topic
- Anthracyclines21 topic
- Congenital Adrenal Hyperplasia21 topic
- Doxorubicin21 topic
- Filaggrin21 topic
- Skin Microbiome21 topic
- Steroid 21-Hydroxylase Deficiency21 topic
Where does John F. Hannigan work?
John F. Hannigan's main affiliation in the publication record is Northern California Research, United States.
How many publications and citations does John F. Hannigan have?
OpenAlex counts 32 works and 2,462 citations for John F. Hannigan, an h-index of 19, ranking #871,251 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about John F. Hannigan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.